The Therapeutic Effects of Combination Therapy with Curcumin and Alendronate on Spine Fusion Surgery in the Ovariectomized Rats
- PMID: 28704906
- PMCID: PMC5518429
- DOI: 10.14245/kjs.2017.14.2.35
The Therapeutic Effects of Combination Therapy with Curcumin and Alendronate on Spine Fusion Surgery in the Ovariectomized Rats
Abstract
Objective: The purpose of this study was to evaluate the therapeutic effects of combination therapy with curcumin and alendronate on spine fusion surgery in ovariectomized rats.
Methods: Thirty-two female Sprague-Dawley rats (12 weeks old) underwent bilateral ovariectomy (OVX). Eight weeks after surgery, animals underwent intertransverse spine fusion at L4-5. The rats were randomly distributed amongst 4 groups; untreated OVX group, curcumin administered group, alendronate administered group, and the combination therapy group. At 8 weeks after fusion surgery, the animals were sacrificed and the fusion mass was assessed by manual palpation, radiographic scan, and micro-computed tomographic scan. In addition, mechanical strength was determined by a 3-point bending test.
Results: Based on the results of manual palpation testing and 3-dimensional micro-computed tomography scanning, solid bone fusion rate was 50% (4 of 8) in the OVX group, 75% (6 of 8) in the alendronate-only and curcumin-only group, and 87.5% (7 of 8) in the combination therapy group, respectively. The combination therapy group had a higher fusion rate compared with the other treatment groups, though not statistically significantly (p>0.05). And the combination therapy group had a significant increase in fusion volume at 8 weeks after spine fusion surgery compared with curcumin-only group (p=0.039). The 3-point bending test showed that combination therapy group had a significantly greater maximal load value compared to that of curcumin-only group (p=0.024).
Conclusion: The present study demonstrated that additional treatment of curcumin and alendronate after spine fusion surgery in rat can promote higher fusion volume, and improve bone mechanical strength.
Keywords: Bone fusion; Curcumin; Osteoporosis; Ovariectomy; Rat.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures




Similar articles
-
A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat.Acta Neurochir (Wien). 2012 Dec;154(12):2215-23. doi: 10.1007/s00701-012-1516-9. Epub 2012 Oct 11. Acta Neurochir (Wien). 2012. PMID: 23053289
-
The influence of alendronate on spine fusion in an osteoporotic animal model.Spine (Phila Pa 1976). 2011 Aug 15;36(18):1446-52. doi: 10.1097/BRS.0b013e3181f49c47. Spine (Phila Pa 1976). 2011. PMID: 21240048
-
Effect of dietary calcium on spinal bone fusion in an ovariectomized rat model.J Korean Neurosurg Soc. 2012 Oct;52(4):281-7. doi: 10.3340/jkns.2012.52.4.281. Epub 2012 Oct 22. J Korean Neurosurg Soc. 2012. PMID: 23133713 Free PMC article.
-
Alendronate Prevents Intervertebral Disc Degeneration Adjacent to a Lumbar Fusion in Ovariectomized Rats.Spine (Phila Pa 1976). 2015 Oct 15;40(20):E1073-83. doi: 10.1097/BRS.0000000000001092. Spine (Phila Pa 1976). 2015. PMID: 26731708
-
Therapeutic advantages of treatment of high-dose curcumin in the ovariectomized rat.J Korean Neurosurg Soc. 2013 Dec;54(6):461-6. doi: 10.3340/jkns.2013.54.6.461. Epub 2013 Dec 31. J Korean Neurosurg Soc. 2013. PMID: 24527187 Free PMC article.
Cited by
-
Therapeutic Potential of Tauroursodeoxycholic Acid for the Treatment of Osteoporosis.Int J Mol Sci. 2020 Jun 16;21(12):4274. doi: 10.3390/ijms21124274. Int J Mol Sci. 2020. PMID: 32560070 Free PMC article.
-
Evaluation of La(XT), a novel lanthanide compound, in an OVX rat model of osteoporosis.Bone Rep. 2021 Feb 11;14:100753. doi: 10.1016/j.bonr.2021.100753. eCollection 2021 Jun. Bone Rep. 2021. PMID: 33665236 Free PMC article.
-
Protective effects of curcumin against osteoporosis and its molecular mechanisms: a recent review in preclinical trials.Front Pharmacol. 2023 Sep 18;14:1249418. doi: 10.3389/fphar.2023.1249418. eCollection 2023. Front Pharmacol. 2023. PMID: 37790808 Free PMC article. Review.
References
-
- Abe Y, Takahata M, Ito M, Irie K, Abumi K, Minami A. Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1–34) in a rat spinal arthrodesis model. Bone. 2007;41:775–785. - PubMed
-
- Adachi JD, Loannidis G, Berger C, Joseph L, Papaioannou A, Pickard L, et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001;12:903–908. - PubMed
-
- Babat LB, McLain R, Milks R, Ferrara L, Sohn MJ. The effects of the antiresorptive agents calcitonin and pamidronate on spine fusion in a rabbit model. Spine J. 2005;5:542–547. - PubMed
-
- Bharti AC, Takada Y, Aggarwal BB. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol. 2004;172:5940–5947. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources